Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

Takeda Pharmaceutical Co Ltd

+ Add to Watchlist

4502:JP

6,111.0 JPY 134.0 2.15%

As of 02:00:00 ET on 03/27/2015.

Snapshot for Takeda Pharmaceutical Co Ltd (4502)

Open: 6,129.0 Day's Range: 6,073.0 - 6,213.0 Volume: 3,376,100
Previous Close: 6,245.0 52wk Range: 4,337.5 - 6,657.0 1-Yr Rtn: +29.40%

Stock Chart for 4502

No chart data available.
  • 4502:JP 6,129.0
  • 1D
  • 1M
  • 1Y
6,245.0
Interactive 4502 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4502

Current P/E Ratio (ttm) 90.3206
Estimated P/E(03/2015) 34.6877
Relative P/E vs. TPX 5.1022
Earnings Per Share (JPY) (ttm) 67.6590
Est. EPS (JPY) (03/2015) 176.1720
Est. PEG Ratio 3.0562
Market Cap (M JPY) 4,826,929.76
Shares Outstanding (M) 789.88
30 Day Average Volume 2,981,800
Price/Book (mrq) 1.9180
Price/Sale (ttm) 2.7567
Dividend Indicated Gross Yield 2.95%
Cash Dividend (JPY) 90.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth 0.00%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4502

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for 4502

Takeda Pharmaceutical Co Ltd focuses on the Research & Development, Manufacturing, Sales and Marketing and Import/Export of Pharmaceutical Drugs. The Company focuses on the following core therapeutic areas: Cardiovascular & Metabolic, Oncology, Central Nervous System, Respiratory & Immunology, General Medicine (Gastrointestinal & Genitourinary) and Vaccine.

Yasuchika HasegawaChief Executive OfficerChristophe WeberPresident/COO
Francois-Xavier RogerChief Financial OfficerTadataka Yamada "Tachi"Chief Medical & Scientific Ofcr
More Company Profile & Key Executives for 4502

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil